Antibiotic Therapy In Respiratory Tract Infections
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
Primary aim: to demonstrate that stopping antibiotic treatment in patients diagnosed with
acute community acquired pneumonia (CAP) based on clinical response has a non-inferior
efficacy 15 days after start of treatment, compared to a conventional predetermined duration
left to the physician's judgement, in adults treated in the community setting.
Secondary aims: To compare the 2 study arms on:
1. Clinical success at late follow up (Day 30),
2. Duration of antibiotic treatment,
3. Frequency and severity of adverse events,
4. Patient's pneumonia symptoms and quality of life.